NASDAQ:TEM Tempus AI (TEM) Stock Price, News & Analysis $62.59 -0.39 (-0.62%) (As of 11/29/2024 05:27 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends About Tempus AI Stock (NASDAQ:TEM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Tempus AI alerts:Sign Up Key Stats Today's Range$62.30▼$67.2250-Day Range$43.34▼$77.6252-Week Range$22.89▼$79.49Volume445,119 shsAverage Volume1.56 million shsMarket Capitalization$9.85 billionP/E RatioN/ADividend YieldN/APrice Target$54.22Consensus RatingModerate Buy Company OverviewTempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.Read More… Is NVDA a sell? Buy this stock instead before Dec 3 (Ad)After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is making headlines for last week's new earnings report – which revealed the AI juggernaut nearly doubled their profits in the last year alone.A 50-year Wall Street veteran gives his answer Nvidia, right here... Tempus AI Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks18th Percentile Overall ScoreTEM MarketRank™: Tempus AI scored higher than 18% of companies evaluated by MarketBeat, and ranked 907th out of 964 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.4 / 5Analyst RatingModerate Buy Consensus RatingTempus AI has received a consensus rating of Moderate Buy. The company's average rating score is 2.70, and is based on 7 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageTempus AI has only been the subject of 4 research reports in the past 90 days.Read more about Tempus AI's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Tempus AI are expected to grow in the coming year, from ($6.15) to ($1.33) per share.Price to Book Value per Share RatioTempus AI has a P/B Ratio of 184.09. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Tempus AI's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.42% of the float of Tempus AI has been sold short.Short Interest Ratio / Days to CoverTempus AI has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Tempus AI has recently increased by 20.46%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTempus AI does not currently pay a dividend.Dividend GrowthTempus AI does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted8.42% of the float of Tempus AI has been sold short.Short Interest Ratio / Days to CoverTempus AI has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Tempus AI has recently increased by 20.46%, indicating that investor sentiment is decreasing significantly. News and Social Media3.3 / 5News Sentiment1.00 News SentimentTempus AI has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Tempus AI this week, compared to 6 articles on an average week.Search Interest23 people have searched for TEM on MarketBeat in the last 30 days. This is an increase of 15% compared to the previous 30 days.MarketBeat Follows21 people have added Tempus AI to their MarketBeat watchlist in the last 30 days. This is an increase of 24% compared to the previous 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Tempus AI insiders have not sold or bought any company stock.Read more about Tempus AI's insider trading history. Receive TEM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tempus AI and its competitors with MarketBeat's FREE daily newsletter. Email Address TEM Stock News HeadlinesMedtronic, Tempus testing AI to find potential TAVR patientsNovember 25, 2024 | finance.yahoo.comTempus to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNovember 25, 2024 | businesswire.com3 Dirt-Cheap Stocks You Can’t Afford to Ignore Often, investors will overlook stocks just because they're cheap. It's a common thought that a cheap price tag means that something must be wrong with the company. But this couldn't be further from the case in many instances.December 1, 2024 | TradingTips (Ad)Tempus AI price target raised to $70 from $40 at Piper SandlerNovember 13, 2024 | markets.businessinsider.comTempus AI downgraded to Hold from Buy at StifelNovember 12, 2024 | markets.businessinsider.comStifel Downgrades Tempus AI (TEM)November 12, 2024 | msn.comTempus AI, Inc.: Valuation Concerns and Growth Uncertainties Justify Hold RatingNovember 12, 2024 | markets.businessinsider.comTempus AI downgraded to hold by Stifel, valuation citedNovember 12, 2024 | msn.comSee More Headlines TEM Stock Analysis - Frequently Asked Questions How have TEM shares performed this year? Tempus AI's stock was trading at $36.48 on January 1st, 2024. Since then, TEM stock has increased by 71.6% and is now trading at $62.59. View the best growth stocks for 2024 here. When did Tempus AI IPO? Tempus AI (TEM) raised $411 million in an initial public offering on Friday, June 14th 2024. The company issued 11,100,000 shares at $37.00 per share. When does the company's lock-up period expire? Tempus AI's lock-up period expires on Wednesday, December 11th. Tempus AI had issued 11,100,000 shares in its public offering on June 14th. The total size of the offering was $410,700,000 based on an initial share price of $37.00. After the expiration of the company's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted. Who are Tempus AI's major shareholders? Tempus AI's top institutional shareholders include NEA Management Company LLC (3.49%), ARK Investment Management LLC (1.54%), Sumitomo Mitsui Trust Group Inc. (0.79%) and Franklin Resources Inc. (0.52%). How do I buy shares of Tempus AI? Shares of TEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Tempus AI own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tempus AI investors own include AST SpaceMobile (ASTS), NVIDIA (NVDA), Broadcom (AVGO), Micron Technology (MU), Recursion Pharmaceuticals (RXRX), Genius Sports (GENI) and Super Micro Computer (SMCI). Company Calendar Today11/30/2024Fiscal Year End12/31/2024Next Earnings (Estimated)2/03/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Computer programming, data processing, & other computer related Sub-IndustryComputer Software Current SymbolNASDAQ:TEM Previous SymbolNASDAQ:TEM CUSIPN/A CIK1717115 Webwww.tempus.com Phone800-976-5448FaxN/AEmployees2,300Year FoundedN/APrice Target and Rating Average Stock Price Target$54.22 High Stock Price Target$70.00 Low Stock Price Target$44.00 Potential Upside/Downside-13.4%Consensus RatingModerate Buy Rating Score (0-4)2.70 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-289,810,000.00 Net MarginsN/A Pretax Margin-190.28% Return on EquityN/A Return on Assets-111.38% Debt Debt-to-Equity Ratio8.17 Current Ratio2.69 Quick Ratio2.55 Sales & Book Value Annual Sales$320.67 million Price / Sales30.73 Cash FlowN/A Price / Cash FlowN/A Book Value$0.34 per share Price / Book184.09Miscellaneous Outstanding Shares157,450,000Free FloatN/AMarket Cap$9.85 billion OptionableN/A BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report This page (NASDAQ:TEM) was last updated on 12/1/2024 by MarketBeat.com Staff From Our PartnersThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, t...Pacaso | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... Th...Chaikin Analytics | SponsoredPaypal, Tesla, SpaceX… Elon's next project is bigger than them allIn February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored***TODAY ONLY*** Is this Trump’s Favorite Coin?Donald Trump just emphatically became America's first crypto president. Trump plans to make America, "the...Weiss Ratings | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredYou’re invited! See my NEWEST trading strategyThis could easily be the most lucrative new trading strategy of 2025... So you’re not going to want to miss...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempus AI, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tempus AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
